Beta Bionics (BBNX), a developer of insulin delivery devices, has set terms for an upsized $165M initial public offering.

Beta Bionics is targeting a valuation of up to $695 million in an upsized initial public offering, the insulin delivery device maker said on Tuesday.

A new study by researchers at Karolinska Institutet and Södersjukhuset shows that advanced ultrasound imaging analyses cannot ...

OS users are set to get the ability to run two WhatsApp accounts, similar to Android users, but with the requirement of two ...

OpenSea, one of the largest multi-chain NFT market platforms, has launched the beta version of its upcoming upgraded NFT ...

Android 16’s first public beta will start rolling out later today, bringing with it dynamic lockscreen notifications for ride ...

Google has just released the Android 16 Beta 1 update for supported Pixel devices. Here's an overview of what's new in this ...

NFT marketplace OpenSea has launched early access to its OS2 platform but with exclusivity granted to Gemesis NFT holders.

Are you an adventurous AirPods user eager to explore the latest features before they're officially released? Beta firmware ...

Apple today released new beta firmware updates for both AirPods 4 models and the AirPods Pro 2 with both Lightning and USB-C ...

Beta Bionics is targeting a valuation of up to $695 million in an upsized initial public offering, the insulin delivery device maker said on Tuesday. The company will aim to raise up to $170 million ...